← Open Payments lookup

OLUYEMI AINA: Open Payments

NPI 1083700041 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,293 in 106 payments from 24 companies in 2025. Trend: 2023 $2,331 · 2024 $1,922 · 2025 $2,293

Food & beverage: $2,281Education: $12
CompanyPaymentsAmount
ABBVIE INC.28$333
Alkermes, Inc.16$301
E.R. Squibb & Sons, L.L.C.8$234
Otsuka America Pharmaceutical, Inc.11$222
Brainsway USA INC1$198
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$147
Eisai Inc.2$138
Teva Pharmaceuticals USA, Inc.3$79
Vanda Pharmaceuticals Inc.3$74
Bausch Health US, LLC3$68

Products named: VRAYLAR, LYBALVI, COBENFY, REXULTI, Deep TMS, CAPLYTA, Leqembi, FANAPT.

Industry payments across TX — which companies pay providers there.